The Astrazeneca share price – where next?

The Astrazeneca (LON:AZN) share price has risen by 1.53% over the past month and it’s currently trading at 8585. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.

According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, Astrazeneca currently has:

• 8 Buy recommendations

• 3 Hold recommendations

• 1 Sell recommendations

This suggests that analysts are generally positive about the outlook.

GET MORE DATA-DRIVEN INSIGHTS INTO LON:AZN »

Going beyond analyst recommendations

At its current price of 8585, shares in Astrazeneca are trading at a discount of -14.0% to its 52 week high price. The 1-year performance of the shares has been 18.5%.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Astrazeneca it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Astrazeneca that you can find out about here.

Alternatively, if you'd like to find more shares that analysts are bullish about, you can find them on this Positive Momentum & Broker Buys screen.